Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis

European Journal of Neuroscience

Volumn 25, Issue 6, 2007, Pages 1669-1677

  Niessen, Heiko G ^a   Debska Vielhaber, Grazyna ^a   Sander, Kerstin ^b   Angenstein, Frank ^a,b   Ludolph, Albert C ^c   Hilfert, Liane ^a   Willker, Wieland ^d   Leibfritz, Dieter ^d   Heinze, Hans Jochen ^a   Kunz, Wolfram S ^e   Vielhaber, Stefan ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

ALS; Amino acids; Brain metabolism; Magnetic resonance spectroscopy; Motor neuron disease

Indexed keywords

4 AMINOBUTYRIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMINE; N ACETYLASPARTIC ACID; TISSUE EXTRACT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL LOSS; CONTROLLED STUDY; DISEASE COURSE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; METABOLIC PARAMETERS; MOTONEURON; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; MUTATION; NERVE DEGENERATION; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 34047245280     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05415.x     Document Type: Article

References (54)

1. Abe, K., Takanashi, M., Watanabe, Y., Tanaka, H., Fujita, N., Hirabuki, N. & Yanagihara, T. (2001) Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology, 43, 537-541.
2. Andrus, P.K., Fleck, T.J., Gurney, M.E. & Hall, E.D. (1998) Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 71, 2041-2048.
3. Angenstein, F., Niessen, H.G., Goldschmidt, J., Vielhaber, S., Ludolph, A.C. & Scheich, H. (2004) Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport, 15, 2271-2274.
4. Block, W., Karitzky, J., Traber, F., Pohl, C., Keller, E., Mundegar, R.R., Lamerichs, R., Rink, H., Ries, F., Schild, H.H. & Jerusalem, F. (1998) Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch. Neurol., 55, 931-936.
5. Boillée, S., Vande Velde, C. & Cleveland, D.W. (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39-59.
6. Boston-Howes, W., Gibb, S.L., Williams, E.O., Pasinelli, P., Brown, R.H. Jr & Trotti, D. (2006) Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J. Biol. Chem., 281, 14076-14084.
7. Bowen, B.C., Pattany, P.M., Bradley, W.G., Murdoch, J.B., Rotta, F., Younis, A.A., Duncan, R.C. & Quencer, R.M. (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol., 21, 647-658.
8. Bruijn, L.I., Miller, T.M. & Cleveland, D.W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 27, 723-749.
9. Chiu, A.Y., Zhai, P., Dal Canto, M.C., Peters, T.M., Kwon, Y.W., Prattis, S.M. & Gurney, M.E. (1995) Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci., 6, 349-362.
10. Choi, C.G. & Frahm, J. (1999) Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn. Reson. Med., 41, 204-207.
11. Chung, Y.H., Joo, K.M., Lee, Y.J. & Cha, C.I. (2003) Immunohistochemical study on the distribution of MnSOD in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res., 990, 215-220.
12. Clark, J.B. (1998) N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci., 20, 271-276.
13. Cooke, F.J., Blamire, A.M., Manners, D.N., Styles, P. & Rajagopalan, B. (2004) Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn. Reson. Med., 51, 1122-1128.
14. Crochemore, C., Pena-Altamira, E., Virgili, M., Monti, B. & Contestabile, A. (2005) Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice. Neurochem. Int., 46, 357-368.
15. Cudkowicz, M., Qureshi, M. & Shefner, J. (2004) Measures and markers in amyotrophic lateral sclerosis. NeuroRx, 1, 273-283.
16. Dal Canto, M.C. & Gurney, M.E. (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol., 145, 1271-1279.
17. El Idrissi, A. & Trenkner, E. (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci., 19, 9459-9468.
18. Fray, A.E., Dempster, S., Williams, R.E., Cookson, M.R. & Shaw, P.J. (2001) Glutamine synthetase activity and expression are not affected by the development of motor neuronopathy in the G93A SOD-1/ALS mouse. Brain Res. Mol. Brain Res., 94, 131-136.
19. Govindaraju, V., Young, K. & Maudsley, A.A. (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed., 13, 129-153.
20. Gurney, M.E. (1994) Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med., 331, 1721-1722.
21. Gurney, M.E. (2000) What transgenic mice tell us about neurodegenerative disease. Bioessays, 22, 297-304.
22. Haenggeli, C. & Kato, A.C. (2002) Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci. Lett., 335, 39-43.
23. Higgins, C.M., Jung, C., Ding, H. & Xu, Z. (2002) Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci., 22, RC215.
24. Hussy, N., Deleuze, C., Desarmenien, M.G. & Moos, F.C. (2000) Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog. Neurobiol., 62, 113-134.
25. Joosten, E.A., Van Westerlaak, M.G., Biesheuvel, C., Woodhams, P.L., Brook, G.A., Veldman, H. & Bar, P.R. (2001) Cellular changes in motoneurons in a transgenic mouse model for amyotrophic lateral sclerosis as revealed by monoclonal antibody Py. Brain Res. Dev. Brain Res., 131, 153-159.
26. Kalra, S., Hanstock, C.C., Martin, W.R., Allen, P.S. & Johnston, W.S. (2006) Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch. Neurol., 63, 1144-1148.
27. Karitzky, J. & Ludolph, A.C. (2001) Imaging and neurochemical markers for diagnosis and disease progression in ALS. J. Neurol. Sci., 191, 35-41.
28. Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D. & Gage, F.H. (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839-842.
29. Kong, J. & Xu, Z. (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci., 18, 3241-3250.
30. Kudin, A., Vielhaber, S., Beck, H., Elger, C.E. & Kunz, W.S. (1999) Quantitative investigation of mitochondrial function in single rat hippocampal slices: a novel application of high-resolution respirometry and laser-excited fluorescence spectroscopy. Brain Res. Brain Res. Prot., 4, 329-334.
31. Leichsenring, A., Linnartz, B., Zhu, X.R., Lubbert, H. & Stichel, C.C. (2006) Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis. Brain Res., 1096, 180-195.
32. Liu, J., Lillo, C., Jonsson, P.A., Vande Velde, C., Ward, C.M., Miller, T.M., Subramaniam, J.R., Rothstein, J.D., Marklund, S., Andersen, P.M., Brannstrom, T., Gredal, O., Wong, P.C., Willams, D.S. & Cleveland, D.W. (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron, 43, 5-17.
33. Malessa, S., Leigh, P.N., Bertel, O., Sluga, E. & Hornykiewicz, O. (1991) Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord. J. Neurol. Neurosurg. Psychiatry, 54, 984-988.
34. Mattiazzi, M., D'Aurelio, M., Gajewski, C.D., Martushova, K., Kiaei, M., Beal, M.F. & Manfredi, G. (2002) Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem., 277, 29626-29633.
35. Niessen, H.G., Angenstein, F., Sander, K., Kunz, W.S., Teuchert, M., Ludolph, A.C., Heinze, H.-J., Scheich, H. & Vielhaber, S. (2006) In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by spin-spin relaxation time and apparent diffusion coefficient. Exp. Neurol., 201, 293-300.
36. Ono, S., Imai, T., Takahashi, K., Jinnai, K., Kanda, F., Fukuoka, Y., Hashimoto, K., Shimizu, N. & Nagao, K. (1999) Alteration in amino acids in motor neurons of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci., 167, 121-126.
37. Pasinelli, P., Belford, M.E., Lennon, N., Bacskai, B.J., Hyman, B.T., Trotti, D. & Brown, R.H. Jr (2004) Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron, 43, 19-30.
38. Perry, T.L., Hansen, S. & Jones, K. (1987) Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology, 37, 1845-1848.
39. Petri, S., Schmalbach, S., Grosskreutz, J., Krampfl, K., Grothe, C., Dengler, R., Van Den Bosch, L., Robberecht, W. & Bufler, J. (2005) The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice. J. Neurol. Sci., 238, 25-30.
40. Petroff, O.A. (2002) GABA and glutamate in the human brain. Neuroscientist, 8, 562-573.
41. Pfeuffer, J., Tkac, I., Provencher, S.W. & Gruetter, R. (1999) Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time 1H NMR spectra of the rat brain. J. Magn. Reson., 141, 104-120.
42. Pioro, E.P., Majors, A.W., Mitsumoto, H., Nelson, D.R. & Ng, T.C. (1999) 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology, 53, 71-79.
43. Plaitakis, A., Constantakakis, E. & Smith, J. (1988) The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol., 24, 446-449.
44. Raiteri, L., Zappettini, S., Stigliani, S., Paluzzi, S., Raiteri, M. & Bonanno, G. (2005) Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis. Neurotoxicology, 26, 883-892.
45. Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., Pestronk, A., Stauch, B.L. & Coyle, J.T. (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol., 28, 18-25.
46. Schuller-Levis, G.B. & Park, E. (2003) Taurine: new implications for an old amino acid. FEMS Microbiol. Lett., 226, 195-202.
47. Suhy, J., Miller, R.G., Rule, R., Schuff, N., Licht, J., Dronsky, V., Gelinas, D., Maudsley, A.A. & Weiner, M.W. (2002) Early detection and longitudinal changes in amyotrophic lateral sclerosis by 1H MRSI. Neurology, 58, 773-779.
48. Vielhaber, S., Kaufmann, J., Kanowski, M., Sailer, M., Feistner, H., Tempelmann, C., Elger, C.E., Heinze, H.-J. & Kunz, W.S. (2001) Effect of creatine supplementation on metabolite levels in ALS motor cortices. Exp. Neurol., 172, 377-382.
49. Vukosavic, S., Stefanis, L., Jackson-Lewis, V., Guegan, C., Romero, N., Chen, C., Dubois-Dauphin, M. & Przedborski, S. (2000) Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci., 20, 9119-9125.
50. Watanabe, M., Dykes-Hoberg, M., Culotta, V.C., Price, D.L., Wong, P.C. & Rothstein, J.D. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis., 8, 933-941.
51. Weydt, P., Hong, S.Y., Kliot, M. & Moller, T. (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport, 14, 1051-1054.
52. Weydt, P. & Moller, T. (2005) Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport, 16, 527-531.
53. Yoshino, Y., Koike, H. & Akai, K. (1979) Free amino acids in motor cortex of amyotrophic lateral sclerosis. Experientia, 35, 219-220.
54. Zang, D.W. & Cheema, S.S. (2002) Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1 (G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett., 332, 99-102.